Individual safety depends on your health history, current conditions, and how your body responds to each medication
cohort study, the 2-year discontinuation rate for GLP-1 receptor agonists was 64.1% among people with type 2 diabetes mellitus, driven by factors such as older age, low income, gastrointestinal adverse events, and insufficient weight loss [115]
The risk of hypoglycaemia with GLP-1 medications is generally low unless they are used in combination with insulin or sulfonylureas
Patients who want or need blood work can access Step One Labs panels starting at approximately $95
A gentler entry point than full-dose therapy for women who want steady, sustainable support
The median (IQR) number of patients across studies was 355 (1295)